LIGAND PHARMACEUTICALS INC

SEC 4 · Filed

0001104659-26-034308Accepted

Applies to the EDGAR acceptance time.

Other time zone
Insider transactionsEvent date Mar 23, 2026

Sale by Sabba Stephen L

Security
Common Stock
Code
S
Shares
1,000
Price per share
207.87Reported 207.8727
Structured facts
{
  "code": "S",
  "date": "2026-03-23",
  "direction": "D",
  "exercise_price": null,
  "expiration": null,
  "footnotes": {
    "F1": "These securities, as represented in Column 5, include a grant of 1,209 restricted shares approved by the Board of Directors of the Company at the 2025 Meeting held 6 June 2025, which shares were previously reported on a Form 4 for this Reporting Person dated 10 June 2025, and are included on this Form 4 only to report that they will vest in full within six (6) months from the date hereof.",
    "F2": "The price, as represented in Column 4, represents an average price per share of the following transactions on 23 March 2026: 100 shares at $208.055000, 17 shares at $207.980000, and 883 shares at $207.850000."
  },
  "owners": [
    {
      "cik": "0001442372",
      "name": "Sabba Stephen L",
      "roles": [
        "director"
      ],
      "title": null
    }
  ],
  "ownership": "D",
  "post_shares": "32793",
  "price": "207.8727",
  "row": 1,
  "rule_10b5_1": "0",
  "security": "Common Stock",
  "shares": "1000",
  "table": "I",
  "underlying_security": null,
  "underlying_shares": null
}